Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System
Authors:
Top Cited Papers
Open Access
- 1 April 2018
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 75 (4) , 405-407
Abstract
As the epidemic of opioid use in the United States continues to shift from prescription opioids to illicit drugs,1 more people living with opioid use disorder are encountering the criminal justice system. Most US correctional facilities do not continue or initiate medications for addiction treatment (MAT).2 This is especially unfortunate given the higher rates of opioid overdose immediately after release from incarceration.3Keywords
This publication has 6 references indexed in Scilit:
- Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 — 10 States, July–December 2016MMWR. Morbidity and Mortality Weekly Report, 2017
- Epidemiology of fentanyl-involved drug overdose deaths: A geospatial retrospective study in Rhode Island, USAInternational Journal of Drug Policy, 2017
- Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods studyInternational Journal of Drug Policy, 2017
- Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in EnglandAddiction, 2017
- Meta‐analysis of drug‐related deaths soon after release from prisonAddiction, 2010
- Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a Nationwide SurveyDrug and Alcohol Dependence, 2009